BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29713012)

  • 1. Prions, prionoids and protein misfolding disorders.
    Scheckel C; Aguzzi A
    Nat Rev Genet; 2018 Jul; 19(7):405-418. PubMed ID: 29713012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders.
    Cherry P; Gilch S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Biology of Prions and Prionoids: A Status Report.
    Aguzzi A; Lakkaraju AKK
    Trends Cell Biol; 2016 Jan; 26(1):40-51. PubMed ID: 26455408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions and prion diseases.
    Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M
    Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein misfolding cyclic amplification of prions.
    Saunders SE; Bartz JC; Shikiya RA
    J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion disease: a tale of folds and strains.
    Kretzschmar H; Tatzelt J
    Brain Pathol; 2013 May; 23(3):321-32. PubMed ID: 23587138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion infection: seeded fibrillization or more?
    Birkmann E; Riesner D
    Prion; 2008; 2(2):67-72. PubMed ID: 19098436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
    Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
    J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
    Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
    J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.